Abstract
Novel anti-cancer treatments use knowledge about the underlying biology of the tumor to find suitable molecular targets. The recent years have seen great advances in understanding the biology of melanoma. In the current review we discuss the most promising molecular targets for melanoma and suggest possible strategies for overcoming resistance.
Keywords: Melanoma, melanocyte, BRAF, PI3K, therapy, cancer, proteasome
Mini-Reviews in Medicinal Chemistry
Title: Towards the Targeted Therapy of Melanoma
Volume: 6 Issue: 4
Author(s): K. S.M. Smalley and M. Herlyn
Affiliation:
Keywords: Melanoma, melanocyte, BRAF, PI3K, therapy, cancer, proteasome
Abstract: Novel anti-cancer treatments use knowledge about the underlying biology of the tumor to find suitable molecular targets. The recent years have seen great advances in understanding the biology of melanoma. In the current review we discuss the most promising molecular targets for melanoma and suggest possible strategies for overcoming resistance.
Export Options
About this article
Cite this article as:
Smalley S.M. K. and Herlyn M., Towards the Targeted Therapy of Melanoma, Mini-Reviews in Medicinal Chemistry 2006; 6 (4) . https://dx.doi.org/10.2174/138955706776361402
DOI https://dx.doi.org/10.2174/138955706776361402 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design Photodynamic Therapy in Melanoma - Where do we Stand?
Current Medicinal Chemistry Management of Vaginal Cancer
Reviews on Recent Clinical Trials Safety and Proof-of-Concept Efficacy of Inhaled Drug Loaded Nano- and Immunonanoparticles in a c-Raf Transgenic Lung Cancer Model
Current Cancer Drug Targets Cratylia mollis Lectin: A Versatile Tool for Biomedical Studies
Current Bioactive Compounds Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters Crocetin, a Carotenoid Derivative, Inhibits VEGF-Induced Angiogenesis via Suppression of p38 Phosphorylation
Current Neurovascular Research Beyond Physical Exercise: The Role of Nutrition, Gut Microbiota and Nutraceutical Supplementation in Reducing Age-Related Sarcopenia
Current Aging Science Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials
Current Medicinal Chemistry Proliferative Activity Of Neokyotorphinrelated Hemoglobin Fragments In Cell Cultures
Protein & Peptide Letters Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Current Drug Targets OX40:OX40L Axis: Emerging Targets for Immunotherapy of Human Disease
Current Immunology Reviews (Discontinued) TGF-β Pathway as a Therapeutic Target in Bone Metastases
Current Pharmaceutical Design ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan
Drug Metabolism Letters Methotrexate: Should We Start Using it in Clinical Practice?
Current Drug Targets CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders
Current Drug Targets Is There a Role for Antioxidants in the Prevention of Infection-Associated Carcinogenesis and in the Treatment of Infection-Driven Tumors?
Current Topics in Medicinal Chemistry HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies
Current Pharmaceutical Design Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Current Pharmaceutical Design